Metoprolol in Critically Ill Patients With COVID-19

BACKGROUND: Severe coronavirus disease-2019 (COVID-19) can progress to an acute respiratory distress syndrome (ARDS), which involves alveolar infiltration by activated neutrophils. The beta-blocker metoprolol has been shown to ameliorate exacerbated inflammation in the myocardial infarction setting....

Descripción completa

Detalles Bibliográficos
Autores principales: Clemente-Moragón, Agustín, Martínez-Milla, Juan, Oliver, Eduardo, Santos, Arnoldo, Flandes, Javier, Fernández, Iker, Rodríguez-González, Lorena, Serrano del Castillo, Cristina, Ioan, Ana-María, López-Álvarez, María, Gómez-Talavera, Sandra, Galán-Arriola, Carlos, Fuster, Valentín, Pérez-Calvo, César, Ibáñez, Borja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. 2021
Materias:
Original Investigations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404624/
https://www.ncbi.nlm.nih.gov/pubmed/34474731
http://dx.doi.org/10.1016/j.jacc.2021.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8404624/
https://www.ncbi.nlm.nih.gov/pubmed/34474731
http://dx.doi.org/10.1016/j.jacc.2021.07.003

Ejemplares similares